Navigation Links
Peregrine Pharmaceuticals Reports Positive Early Results in Phase II Study of Bavituximab in Breast Cancer
Date:7/2/2008

ements within the meaning of the Private Securities Litigation Reform Act of 1995. The forward-looking statements involve risks and uncertainties including, but not limited to, the risk that the results of the subsequent stage for this trial will not be consistent with the results of the first stage. It is important to note that the company's actual results could differ materially from those in any such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, uncertainties associated with completing preclinical and clinical trials for our technologies; the early stage of product development; the significant costs to develop our products as all of our products are currently in development, preclinical studies or clinical trials; obtaining additional financing to support our operations and the development of our products; obtaining regulatory approval for our technologies; anticipated timing of regulatory filings and the potential success in gaining regulatory approval and complying with governmental regulations applicable to our business. Our business could be affected by a number of other factors, including the risk factors listed from time to time in the company's SEC reports including, but not limited to, the annual report on Form 10-K for the year ended April 30, 2007 and the quarterly report on Form 10-Q for the quarter ended January 31, 2008. The company cautions investors not to place undue reliance on the forward-looking statements contained in this press release. Peregrine Pharmaceuticals, Inc. disclaims any obligation, and does not undertake to update or revise any forward-looking statements in this press release.

Contacts:

GendeLLindheim BioCom Partners

Investors Media

info@peregrineinc.com Barbara Lindheim

(800) 987-8256 (212) 918-4650


'/>"/>
SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
2. Peregrine Pharmaceuticals Awarded Two New U.S. Patents Broadening Its Targeted Anti-Phospholipid Patent Portfolio
3. Data To Be Presented at ASCO Supports Potential of Peregrines Cotara(R) for the Treatment of Brain Cancer
4. Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Bavituximab Phase II Breast Cancer Trial
5. Peregrine Researchers Present New Preclinical Data at AACR Annual Meeting Confirming Unique Anti-Tumor Mechanism of Bavituximab
6. Preclinical Study Presented at AACR Annual Meeting Shows Peregrines Anti-PS Immunocytokines Can Generate Protective Immune Responses in a Highly Aggressive Breast Cancer Model
7. Preclinical Study Presented at AACR Annual Meeting Shows Broad Anti-Cancer Potential of Peregrines anti-PS Vascular Targeting Antibodies
8. Clinical Experience With Peregrines Anti-Cancer Agent Bavituximab Presented at Leading Symposium on Anti-Angiogenic Agents
9. Peregrine Pharmaceuticals Opens Enrollment in Phase II Clinical Trial of Bavituximab in Patients with Advanced Breast Cancer
10. Peregrine Pharmaceuticals Receives Approval to Conduct a Second Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
11. Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... , Sept. 16, 2014  Decision Resources Group finds that ... $14 billion in 2013 to over $18.2 billion in 2023 in ... , Germany , Italy , ... and Japan . TNF-alpha inhibitors will remain ... the RA market, but growth will be constrained and patient shares ...
(Date:9/16/2014)... , Sept. 16, 2014   Evana Automation ... custom, automated assembly and test systems, recently received a ... leading medical device manufacturer. The Evana solution will help ... and ergonomics, as well as reduce labor. ... fed to Evana,s robotic assembly cell. The robot will ...
(Date:9/16/2014)... , Sept. 16, 2014 The ... Directors Institute has simultaneously released the NAMCP Medical ... Medical Diagnostics Dossier Template © , which provide ... formats for either medical devices or diagnostics that ... of each of these technology types (instead of ...
Breaking Medicine Technology:The Rheumatoid Arthritis Drug Market Will Grow to $18.2 Billion in 2023, Driven by the Uptake of Oral Jak Inhibitors and Non TNF-alpha Biologics 2The Rheumatoid Arthritis Drug Market Will Grow to $18.2 Billion in 2023, Driven by the Uptake of Oral Jak Inhibitors and Non TNF-alpha Biologics 3Evana Automation to Supply Robotic Assembly Cell to Leading Medical Device Manufacturer 2Evana Automation to Supply Robotic Assembly Cell to Leading Medical Device Manufacturer 3NAMCP Medical Directors Institute releases NAMCP Medical Technologies and Diagnostics Dossier Templates to provide model approach for medical devices or diagnostics 2
... world-leading developer and marketer of innovative medical technologies for ... Bradford (Brad) Barton as President, ConvaTec U.S.   ... the ConvaTec U.S. organization across the company,s three core ... and Critical Care.   Barton joined ConvaTec ...
... SPRING, Md., Nov. 9, 2010 The U.S. Food ... undergoing computed tomography (CT) brain perfusion scans were accidently ... properly used, the CT scanners did not malfunction. Instead, ... scanners resulted in these overdoses. However, the FDA has ...
Cached Medicine Technology:Bradford Barton Named President, ConvaTec U.S. 2FDA Working to Prevent Radiation Overdoses During CT Scans 2FDA Working to Prevent Radiation Overdoses During CT Scans 3
(Date:9/16/2014)... HORAN, a leading advisor in employee benefits ... as Vice President – Retirement Services. , Paul works ... planning. In addition, he monitors investments, fees and providers ... has been a retirement services industry professional for over ... a Senior Investigator at the Department of Labor facilitates ...
(Date:9/16/2014)... 16, 2014 Since the adoption of ... risen considerably in line with increased investment in R&D ... labels include novel paediatric information and more than 130 ... European countries, there has been 221 changes relating to ... submission of old or new trials in children and ...
(Date:9/16/2014)... 2014 This month’s issue features a ... newly elected chairman, Robert Vail of Vail Automotive in ... further the causes of the state’s franchised new car ... the retail automotive industry’s top names including Jenn Reid ... important to take a “360 view” of the customer ...
(Date:9/16/2014)... 2014 LiveOps, the global leader ... announced today that the company has received a ... the creation of a social learning ecosystem and ... Group honors companies that have successfully developed and ... that have helped companies achieve measurable results. This ...
(Date:9/16/2014)... Hudson County, NJ (PRWEB) September 16, 2014 ... that a leading Bariatric Surgeon, Leigh Montes, MD, ... of Bariatric Surgery at Christ Hospital. Our system ... Bariatric Center, a medical and surgical weight loss ... through the most advanced bariatric surgery procedures, including ...
Breaking Medicine News(10 mins):Health News:Paul Carl Joins HORAN's Retirement Plan Consulting Organization 2Health News:Paediatric Drug Development Market Analysed by CBR Pharma Insights in In-demand Report Available at MarketPublishers.com 2Health News:Paediatric Drug Development Market Analysed by CBR Pharma Insights in In-demand Report Available at MarketPublishers.com 3Health News:September Issue of Car Biz Today Magazine Available Online 2Health News:LiveOps Wins Silver At The 2014 Brandon Hall Group Excellence In Learning Awards For Best Use Of Social/Collaborative Learning 2Health News:LiveOps Wins Silver At The 2014 Brandon Hall Group Excellence In Learning Awards For Best Use Of Social/Collaborative Learning 3Health News:LiveOps Wins Silver At The 2014 Brandon Hall Group Excellence In Learning Awards For Best Use Of Social/Collaborative Learning 4Health News:Top Bariatric Surgeon Joins CarePoint Health 2Health News:Top Bariatric Surgeon Joins CarePoint Health 3
... When the Spanish capital Madrid decided to replace the thin ... the kind of move that millions of women// around the ... measures to ban very skinny fashion models and to promote ... international interest, a spokesman for the regional government says. ...
... recent research shows that the translaminar approach to cervical ... percent of those treated. ,In addition ... found to be safer than an alternative method or ... alternative approach, steroids are injected in close proximity to ...
... kick the butt. There will be no escape into outdoor areas ... bill// of British Columbia hits the public. ,The new ... in all indoor public spaces as well as in public doorways, ... accessible by the public. , Says Health Minister George ...
... it comes to health care for our kids, we live ... tougher. That is the underlying message// from three University of ... complete overhaul of the U.S child health care system. ... issue of the journal Health Affairs, Dr. Neal Halfon, director ...
... found two of three newer antipsychotic drugs are more ... older medication, according to a research. ,The ... longstanding Clinical Antipsychotic Trials for Intervention Effectiveness (CATIE). Dr. ... School of Medicine, is the lead author. ...
... specialists have underlined the urgency to uplift end of life care. ... the flaws// in the healthcare system that do not adequately ... ,Our health care systems do not reliably meet the needs of ... write Sydney Dy and Joanne Lynn, two palliative care doctors based ...
Cached Medicine News:Health News:Spain Launches Movement Against Skinny Fashion Models 2Health News:Spain Launches Movement Against Skinny Fashion Models 3Health News:Neck Pain Treatment Safer Without Significant Risk of Paralysis 2Health News:U.S. Child Health System Needs Total Overhaul 2Health News:Study Sheds Light on Value of Newer Antipsychotic Drugs for Schizophrenia 2Health News:Care During Last Phase of Life Needs to Be Uplifted 2
Lombart clip-on occluder...
9 inch double ended with one end black and the other end with 49 holes...
Double Ended Occluders...
Long handle occluders are approximately 9 inches long....
Medicine Products: